Browse clinical instruments

… follow-up. Patient-reported outcomes were collected, including Visual Analog Scale (VAS) for pain, painDETECT questionnaire for neuropathic pain c…

…50). The primary outcome was pain intensity, assessed using the Numeric Rating Scale (NRS) at 7 days, 30 days, 3 months, and 6 months. Secondary out…

…, and 3, 6 months. Secondary outcomes included quality of life (EQ-5D-5L), opioid consumption, and neurological complications.Results…

…imensions 5-Levels, EQ-5D-5L), dermatology-specific instrument (Dermatology Life Quality Index, DLQI) and acne-specific instrument (Cardiff Acne Disability In…

…mbolysis compared with standard medical care. Outcomes included EQ-5D three-level version (EQ-5D-3L, composite and individual non-mot…

…Baseline 3 -months Between-group difference of change (95% CI ) EQ-5D Utility Index 0.55 (0.34) 0.60 (0.24) 0.54 (0.25) 0.55 (0.30) 0…

… performed by combining the healthcare resource cost and 1-year EQ-5D (giving a quality-adjusted life-year (QALY)) using statistical …

…t-related adverse effects, and 1 item is an epilepsy disability visual analogue scale. Higher SERIAS scores indicate greater disability. SERIAS was c…

…mobility, self-care, activity, pain, anxiety/depression – and a visual analogue scale (VAS) scale (0–100). Univariable and multivariable logistic reg…

…he early treatment group, but only 1 (7%) in the delayed group. EQ-5D-3L utility value at discharge was significantly higher for earl…

…. Patients were followed for 5 years, with assessments of pain (Numerical Rating Scale (NRS)), disability (Oswestry Disability Index (ODI)), and healt…

…gnificantly over time. Additionally, participants completed the EQ-5D questionnaire during the same period, allowing for direct compa…